SavedAdd your journal

Journals / Türk Yoğun Bakım Dergisi / 2013 / Cilt: 11 - Sayı: 3

Sepsis and Extracorporeal Membrane Oxygenation (ECMO)

Sepsis ve Ekstrakorporeal Membran Oksijenizasyonu

MUSTAFA KEMAL ARSLANTAŞ
İsmail CİNEL
Ali GÜNERLİ
Pages
86–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since application of ECMO provides us with a way to mitigate or avoid the traumatic effects of mechanical ventilation, it is one of the most debated issues in the relevant literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sepsis and sepsis related organ dysfunctions are leading causes of mortality and morbidity in intensive care units.
📊
Key Findings & Data:In severe sepsis, cardiovascular system failure including myocardial dysfunction/ vasoplegia and respiratory failure along with trending down of PaO2/FiO2 ratio are frequently present together.
💡
Conclusion & Impact:Since application of ECMO provides us with a way to mitigate or avoid the traumatic effects of mechanical ventilation, it is one of the most debated issues in the relevant literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sepsis and sepsis related organ dysfunctions are leading causes of mortality and morbidity in intensive care units. In severe sepsis, cardiovascular system failure including myocardial dysfunction/ vasoplegia and respiratory failure along with trending down of PaO2/FiO2 ratio are frequently present together. Extracorporeal Membrane Oxygenation (ECMO) is being used more often in intensive care to maintain oxygenation in cases of acute or reversible lung injury/myocardial dysfunction which is recalcitrant to traditional therapy. Since application of ECMO provides us with a way to mitigate or avoid the traumatic effects of mechanical ventilation, it is one of the most debated issues in the relevant literature.

Özet

Sepsis ve sepsisin yol açtığı organ yetersizlikleri yoğun bakımlardaki mortalite ve morbiditenin en önemli nedenlerindendir. Şiddetli sepsiste, çoğunlukla miyokardiyal disfonksiyon ve vasoplejinin gözlemlendiği kardiyovasküler sistem tutulumu ve PaO2/ FiO2 oranının azalma trendinde olduğu solunum sistemi tutulumu birliktedir. Ekstrakorpereal membran oksijenasyonu (“Extracorporeal Membrane Oxygenation” ECMO) geleneksel tedavi ile sonuç alınamayan akut ve geri dönüşümlü akciğer veya kalp-akciğer hasarında yeterli oksijenasyonu sağlamakta işlev gören, yeni bir yaklaşım olarak günümüzde yoğun bakımlarda giderek daha sık kullanılmaya başlanmıştır. Uygulamanın, organizmanın homeostazisi ile doğrudan ilişkili ve mekanik ventilasyonun travmatik zararlarından kaçınmayı sağlayabilecek bir yöntem olması ECMO kullanımını sepsiste güncel hale getirmektedir.

🔖

Cite This Article

ARSLANTAŞ, M. K., CİNEL, İ., GÜNERLİ, A. (2013). Sepsis and Extracorporeal Membrane Oxygenation (ECMO). Türk Yoğun Bakım Dergisi, Cilt: 11 - Sayı: 3, 86–92. https://ajindex.com/articles/327841

References (16)

  1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(7 Suppl):S109-16
  2. Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet 2013;381(9868):774-5
  3. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13(3):260-8
  4. Artenstein AW, Higgins TL, Opal SM. Sepsis and Scientific Revolutions. Crit Care Med 2013;41(12):2770-2
  5. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009;37(1):291-304
  6. Cinel I, Oral U. Sepsiste patojenik mekanizmalar. Türk Yoğun Bakım Dergisi 2003;1(4):15-28
  7. Cinel IR, Nanda RP. Dellinger. Cardiac dysfunction in septic shock. Yearbook of Intensive Care and Emergency Medicine: Springer Berlin Heidelberg; 2008. p. 43-54
  8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-77
  9. Cinel I, Dellinger RP. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 2007;20(4):345-52
  10. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39(2):165-228
  11. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002166(1):98-104
  12. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32(9):1825-31
  13. De Backer D, Donadello K, Sakr Y, Ospina-Tascon G, Salgado D, Scolletta S, et al. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med 2013;41(3):791-9
  14. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2(7511):319-23
  15. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-24
  16. Villar J, Perez-Mendez L, Lopez J, Belda J, Blanco J, Saralegui I, et al. An early PEEP/FIO2 trial identifies different